287 related articles for article (PubMed ID: 4075093)
21. Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons.
Prasad C; Ikegami H; Shimizu I; Onaivi ES
Life Sci; 1994; 54(16):1169-84. PubMed ID: 8152341
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin-immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions.
Salin P; Kerkerian-Le Goff L; Heidet V; Epelbaum J; Nieoullon A
Brain Res; 1990 Jun; 521(1-2):23-32. PubMed ID: 1976412
[TBL] [Abstract][Full Text] [Related]
23. Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
Carey RJ
Exp Neurol; 1986 Jun; 92(3):591-600. PubMed ID: 3086112
[TBL] [Abstract][Full Text] [Related]
24. The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585.
Roberts JC; Reavill C; East SZ; Harrison PJ; Patel S; Routledge C; Leslie RA
Brain Res; 2002 Apr; 934(1):49-57. PubMed ID: 11937069
[TBL] [Abstract][Full Text] [Related]
25. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
Demarest KT; Lawson-Wendling KL; Moore KE
Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
[No Abstract] [Full Text] [Related]
26. Striatal lesions and transplants demonstrate that cholecystokinin receptors are localized on intrinsic striatal neurones: a quantitative autoradiographic study.
Beresford IJ; Hall MD; Clark CR; Hill RG; Hughes J; Sirinathsinghji DJ
Neuropeptides; 1987; 10(2):109-36. PubMed ID: 2960910
[TBL] [Abstract][Full Text] [Related]
27. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection.
Janson AM; Fuxe K; Agnati LF; Kitayama I; Härfstrand A; Andersson K; Goldstein M
Brain Res; 1988 Jul; 455(2):332-45. PubMed ID: 2900058
[TBL] [Abstract][Full Text] [Related]
28. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
Koob GF; Simon H; Herman JP; Le Moal M
Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
[TBL] [Abstract][Full Text] [Related]
29. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
Roger LJ; Breese GR; Morell P
Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
[TBL] [Abstract][Full Text] [Related]
30. Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine]enkephalin (125I-DPDPE).
Dilts RP; Kalivas PW
Synapse; 1990; 6(2):121-32. PubMed ID: 1978419
[TBL] [Abstract][Full Text] [Related]
31. Increases in [3H]FK-506 and [3H]L-N(G)-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation.
Araki T; Tanji H; Fujihara K; Kato H; Itoyama Y
Metab Brain Dis; 1999 Mar; 14(1):21-31. PubMed ID: 10348311
[TBL] [Abstract][Full Text] [Related]
32. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development.
Janhunen S; Ahtee L
Neurosci Biobehav Rev; 2007; 31(3):287-314. PubMed ID: 17141870
[TBL] [Abstract][Full Text] [Related]
33. Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system.
Dilts RP; Kalivas PW
Brain Res; 1989 May; 488(1-2):311-27. PubMed ID: 2545303
[TBL] [Abstract][Full Text] [Related]
34. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra.
Cruz CJ; Beckstead RM
Neuroscience; 1989; 30(2):331-8. PubMed ID: 2473415
[TBL] [Abstract][Full Text] [Related]
35. Altered melatonin MT
Kang NH; Carriere CH; Bahna SG; Niles LP
Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
[TBL] [Abstract][Full Text] [Related]
36. Different interactions of prolyl oligopeptidase and neurotensin in dopaminergic function of the rat nigrostriatal and mesolimbic pathways.
Peltonen I; Myöhänen TT; Männistö PT
Neurochem Res; 2012 Sep; 37(9):2033-41. PubMed ID: 22729983
[TBL] [Abstract][Full Text] [Related]
37. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
Deutch AY; Tam SY; Freeman AS; Bowers MB; Roth RH
Eur J Pharmacol; 1987 Feb; 134(3):257-64. PubMed ID: 3569414
[TBL] [Abstract][Full Text] [Related]
38. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.
Herkenham M; Lynn AB; de Costa BR; Richfield EK
Brain Res; 1991 May; 547(2):267-74. PubMed ID: 1909204
[TBL] [Abstract][Full Text] [Related]
39. Light and electron microscopic localization of retrogradely transported neurotensin in rat nigrostriatal dopaminergic neurons.
Castel MN; Woulfe J; Wang X; Laduron PM; Beaudet A
Neuroscience; 1992 Sep; 50(2):269-82. PubMed ID: 1279459
[TBL] [Abstract][Full Text] [Related]
40. Hyperactivity in the offspring of nicotine-treated rats: role of the mesolimbic and nigrostriatal dopaminergic pathways.
Richardson SA; Tizabi Y
Pharmacol Biochem Behav; 1994 Feb; 47(2):331-7. PubMed ID: 8146225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
